Ted Bililies, PhD, is a Managing Director at AlixPartners and the firm’s first Chief Talent Officer. Bililies has worked with boards, global investors, and CEOs around the world on their toughest talent issues, including how to assess, align, and develop talent in their top teams; how to select and develop the next generation of an organization’s leadership; and how to leverage talent strategically to position organizations for maximum profitability and financial success. He has helped global leaders achieve enduring change in their organizations, in their teams, and in themselves by expanding their psychological, behavioral, and organizational intelligence and insight.

Pilar Tarry is a Director in AlixPartners’ Turnaround and Restructuring Services group. She helps large and middle-market companies devise and implement complex restructuring solutions, primarily within a court-supervised framework. She brings more than 15 years of expertise to bear in helping clients with contingency planning and case management, negotiation of the recapitalization of debt obligations, and the design of crisis communication programs by leading vendor management programs and implementing restructuring transactions, primarily section 363 sales and recapitalization transactions. Tarry holds an MBA in finance from Michigan State University and is a Certified Insolvency and Restructuring Advisor.

Megan Broker brings 18 years of business experience managing numerous large scale projects across a variety of industries. As a process improvement specialist, Broker is adept at quickly and effectively assessing client needs, generating turn-key operational designs and services, building process efficiency necessary to support and achieve key deliverables. As an effective strategic partner, she is able to quickly assess, discern critical competency drivers and customize highly targeted client solutions aligned to strategic organizational outcomes. Leadership development training programs are a particular content expertise, especially within the energy and pharmaceutical sectors.